Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

NCT01486381 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S